EDGAR Filing Documents for 0001193125-20-212104

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-20-212104

Filing Date

2020-08-06

Accepted

2020-08-06 17:27:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5)	d21070d424b5.htm	424B5	356483
2	GRAPHIC	g21070g08c20.jpg	GRAPHIC	36896
	Complete submission text file	0001193125-20-212104.txt		408323

Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306

Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235655 | Film No.: 201082909
SIC: 2836 Biological Products, (No Diagnostic Substances)